These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-000083-27 A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass tablet Phleum pratense in subjects with seasonal grass pollen induced rhin... 2009-11-09 bad-data
No trial status on register 2004-001316-31 TOLERABILIDAD DE LAS VACUNAS ALERGÉNICAS VALORADAS EN UNIDADES DE MASA Y ADMINISTRADAS POR VÍA SUBLINGUAL. ESTUDIO RANDOMIZADO DOBLE CIEGO CONTROLADO CON PLACEBO EN PACIENTES CON ENFERMEDAD ALÉRGICA R... bad-data
Reported results 2004-004924-11 A multicentre, randomised, double-blind, placebo-controlled parallel group clinical trial to investigate the efficacy and safety of specific sublingual immunotherapy with SLIT One birch in patients wi... 2006-08-30 due-trials
Ongoing, reported early 2005-001573-10 ESTUDIO DOBLE CIEGO CONTROLADO CON PLACEBO DE INMUNOTERAPIA CON UN EXTRACTO DE Dermatophagoides MEZCLA COMO TRATAMIENTO DEL ASMA PERSISTENTE LEVE-MODERADO Y SU PAPEL AHORRADOR DE MEDICACIÓN DE FONDO not-yet-due
Ongoing, reported early 2005-003460-35 Evaluación de los cambios inmunológicos tras la inmunoterapia subcutánea con un extracto de Phleum pratense not-yet-due
Reported results 2005-004675-37 Multicenter, randomized, double-blind, placebo-controlled parallel group study to demonstrate the efficacy of a 12-month subcutaneous specific immunotherapy with ALK-depot SQ Milbenmischung in patient... 2009-05-28 due-trials
Reported results 2005-004724-39 A randomised, parallel-group, open, controlled Phase III trial assessing the treatment compliance with GRAZAX in subjects with seasonal grass pollen induced rhinoconjunctiviits 2007-11-21 due-trials
Ongoing, reported early 2005-004731-21 Estudio doble ciego controlado con placebo para evaluar la eficacia de SLITone en pacientes alérgicos a ácaros de polvo de casa. not-yet-due
Ongoing, reported early 2005-004962-18 A randomised, double-blind, placebo-controlled, multi-centre Phase I Trial investigating the safety of ALK Grass tablet in children aged 5-12 years with grass pollen induced rhinoconjunctivitis (with/... not-yet-due
Completed, reported early 2005-005402-22 A randomised, double-blind, placebo-controlled, multi-centre Phase I Trial investigating the safety of GRAZAX-R in children aged 5-12 years with grass pollen induced rhinoconjunctivitis (with/without ... 2006-04-25 not-yet-due
Ongoing, reported early 2005-005636-28 Valoración de la eficacia a corto plazo de un extracto de Dermatophagoides pteronyssinus, valorado en unidades de masa y administrado por vía subcutánea, en el tratamiento del asma alérgico. Estudio r... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001795-20 A phase II-III trial assessing the efficacy and safety of three doses of the ALK HDM tablet in house dust mite allergic subjects. 2008-07-03 bad-data
Reported results 2006-003415-46 A phase III trial investigating the efficacy and safety of Grazax in children aged 5-16 years with grass pollen induced rhinoconjunctivitis with or without asthma 2007-11-07 due-trials
Completed, but no date, and reported results 2006-004820-35 Multicenter, randomized, parallel groups, semi-cross over, open Phase IIIB trial to evaluate treatment compliance for subglossal specific Immunotherapy oral lyophilisate tablets GrazaxR in patients ... bad-data
Ongoing, reported early 2006-005263-26 A randomised, double-blind, placebo-controlled Phase IIIb Study investigating changes in immunological parameters and cutaneous reactivity induced by a short course immunotherapy with ALK grass tablet... not-yet-due
Ongoing, reported early 2007-000402-67 Estudio multicéntrico, randomizado, doble ciego-placebo en Fase I para evaluar la seguridad en niños del liofilizado oral ALK de ácaros not-yet-due
Reported results 2007-000921-23 A randomised, parallel-group, double-blind, placebo-controlled, multicentre Phase III trial assessing the pharmacodynamic efficacy and safety of an intraseasonal short-time updosing schedule for Aluta... 2008-10-31 due-trials
Reported results 2007-006009-26 A Phase III trial assessing the pharmacodynamic efficacy and the tolerability of Grazax® treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivit... 2009-02-03 due-trials
Completed, but no date, and reported results 2008-000196-23 Efficacy of sublingual immunotherapy with HDM mix extract (Der p and Der f) (SLITone) in pediatric subjects with mild-to-moderate atopic eczema (AE) and sensitization to HDM (SPT positive). bad-data
Reported results 2008-003593-18 A Phase III trial evaluating the tolerability of Grazax treatment in combination with antihistamine in subjects with seasonal grass pollen induced rhinoconjunctivitis 2009-02-27 due-trials
Reported results 2008-006921-14 A multicentre randomised Phase II clinical trial to demonstrate equivalent pharmacodynamic efficacy and tolerability of two updosing schedules for ALK-Flex SQ 2009-06-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011235-12 A Randomised,parallel-group,double-blind,placebo-controlled,multi-national,Phase III trial investigating the asthma preventing effect of Grazax compared to placebo in children with grass pollen induce... 2015-09-30 bad-data
Completed, but no date, and reported results 2009-011453-41 Mecanismos moleculares y celulares de rinitis alérgica en pacientes tratados con GRAZAX® -"Molecular and cellular mechanism in rhinitis allergic patients treated with GRAZAX®" bad-data
Reported results 2009-014522-41 An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergy 2013-07-02 due-trials
Reported results 2009-014580-39 A multicentre randomised Phase II clinical pilot study to compare the pharmacodynamic efficacy and tolerability of the sublingual and the vestibular administration route for SLITonePLUS® Birch 2010-12-21 due-trials
Completed, but no date, and reported results 2009-014923-22 A phase IIIB trial investigating 3-year treatment efficacy, tolerability and safety of Grazax in children aged 5-18 years with grass pollen induced rhinoconjunctivitis with/without controlled contro... bad-data
Listed as ongoing, but also has a completion date and reported results 2010-018621-19 Efficacy of ALK house dust mite allergy immunotherapy tablet in subjects with house dust mite induced asthma. 2013-06-25 bad-data
Completed, but no date, and reported results 2011-000057-23 Estudio abierto para valorar la tolerabilidad de la inmunoterapia con AVANZ Phleum pratense bad-data
Reported results 2011-000120-15 AVANZ Phleum pratense maintenance dose 2012-12-21 due-trials
Ongoing, reported early 2011-002017-11 Estudio abierto para evaluar la tolerabilidad de la inmunoterapia con AVANZ Dermatophagoides mezcla not-yet-due
Reported results 2011-002277-38 A one-year trial evaluating the efficacy and safety of the ALK house dust mite allergy immunotherapy tablet in adult subjects with house dust mite allergic rhinitis 2013-08-04 due-trials
Ongoing, reported early 2011-004852-20 An open trial to assess the tolerability of AVANZ Olive immunotherapy not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000031-59 A dose-response evaluation of ALK tree AIT 2013-09-17 bad-data
Ongoing, reported early 2012-002177-62 A Dose Response Evaluation of SLIToneULTRA HDM Mix Immunotherapy not-yet-due
Completed, but no date, and reported results 2012-005092-14 Molecular and Cellular Mechanism in the course of Immunotherapy with a Phleum pratense oral lyophilisate bad-data
Completed, but no date, and reported results 2013-001728-20 An open trial to assess the tolerability of AVANZ® Salsola immunotherapy bad-data
Completed, but no date, and reported results 2013-004720-11 An open trial to assess the tolerability of AVANZ® Cupressus immunotherapy bad-data
Reported results 2013-005130-38 Evaluation of the efficacy and safety of AVANZ® Phleum pratense in grass pollen-induced allergic rhinitis during controlled exposure in an environmental challenge chamber 2015-10-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2015-004821-15 Efficacy and safety of the SQ tree SLIT-tablet in subjects with moderate to severe allergic rhinitis and/or conjunctivitis induced by pollen from the birch group 2017-06-20 bad-data
Other 2016-004363-39 A phase III trial evaluating the efficacy and safety of the house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet in children and adolescents (5-17 years) with HDM allergic asthma not-yet-due
Completed, reported early 2017-000971-97 Safety and tolerability of shortened up-dosing with Alutard SQ 2018-05-29 not-yet-due